Related Experiment Video
Updated: May 18, 2026
06:24
Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Pediatric photosensitivity.
1Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. annie.grossberg@gmail.com
Photodermatology, Photoimmunology & Photomedicine
|September 29, 2012
Summary
Pediatric photosensitivity, though rare, has diverse causes including primary conditions, dermatoses, genodermatoses, and metabolic disorders. Recognizing these is crucial for proper diagnosis and management.
Area of Science:
- Pediatric Dermatology
- Photodermatology
Background:
- Photosensitivity is uncommon in children.
- Causes range from primary idiopathic conditions to photoexacerbation of existing skin diseases.
- Genodermatoses, metabolic, and connective tissue disorders can also manifest with photosensitivity.
Purpose of the Study:
- To provide a diagnostic and management approach for pediatric photosensitivity.
- To aid dermatologists and pediatricians in recognizing diverse causes.
- To outline necessary evaluations and management strategies.
Main Methods:
- Literature review of pediatric photosensitivity.
- Synthesis of information on various etiologies.
- Development of a structured approach for clinical practice.
Main Results:
- Photosensitivity in children stems from varied origins.
- Differential diagnosis includes primary conditions, dermatoses, genodermatoses, metabolic, and connective tissue disorders.
- Recognition of associated stigmata and appropriate workup are key.
Conclusions:
- A systematic approach is essential for diagnosing pediatric photosensitivity.
- Understanding the spectrum of causes aids in timely and accurate diagnosis.
- Effective management relies on identifying the underlying etiology.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...